WallStSmart

SUNation Energy Inc. (SUNE)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 260% more annual revenue ($258.90M vs $71.91M). SUNE leads profitability with a -15.1% profit margin vs -15.5%. SUNE earns a higher WallStSmart Score of 45/100 (D).

SUNE

Hold

45

out of 100

Grade: D

Growth: 8.0Profit: 3.0Value: 5.0Quality: 4.5
Piotroski: 5/9Altman Z: -0.14

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SUNE.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SUNE2 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
77.0%10/10

Revenue surging 77.0% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

SUNE4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$4.16M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-66.2%2/10

ROE of -66.2% — below average capital efficiency

Altman Z-ScoreHealth
-0.142/10

Distress zone — elevated risk

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : SUNE

The strongest argument for SUNE centers on Price/Book, Revenue Growth. Revenue growth of 77.0% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : SUNE

The primary concerns for SUNE are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

SUNE carries more volatility with a beta of 3.79 — expect wider price swings.

SUNE is growing revenue faster at 77.0% — sustainability is the question.

Monitor SOLAR industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SUNE scores higher overall (45/100 vs 41/100) and 77.0% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

SUNation Energy Inc.

TECHNOLOGY · SOLAR · USA

SUNation Energy Inc. is a leading provider of solar energy solutions, specializing in the design, installation, and maintenance of solar photovoltaic systems for both residential and commercial markets. Committed to sustainability and environmental responsibility, the company leverages advanced technologies to enhance energy efficiency while reducing costs for its clientele. As the shift towards renewable energy accelerates globally, SUNation's dedication to innovation and customer satisfaction solidifies its role as a crucial contributor to the renewable energy landscape, capitalizing on the growing demand for clean energy alternatives.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?